Apollo Endosurgery Inc IPO év
Mi az Apollo Endosurgery Inc IPO év?
A IPO év az Apollo Endosurgery Inc - 2012
Mi a IPO év meghatározása?
A kezdeti nyilvános ajánlattétel olyan nyilvános ajánlattétel, amelyben a társaság részvényeit általában olyan intézményi befektetőknek adják el, akik viszont értékpapírcserében először értékesítik a nagyközönségnek.
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
IPO év a Health Care szektor a NASDAQ-on cégekben a Apollo Endosurgery Inc -hoz képest
Mit csinál Apollo Endosurgery Inc?
Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.
ipo év -hoz hasonló cégek Apollo Endosurgery Inc
- American Century ETF Trust nak IPO év 2011 van
- Sino Harbour nak IPO év 2011 van
- Horizons Gold Prod Equty Cvrd C nak IPO év 2011 van
- HFX nak IPO év 2011 van
- Dark Horse Resources nak IPO év 2011 van
- Om Metals Infraprojects nak IPO év 2011 van
- Apollo Endosurgery Inc nak IPO év 2012 van
- Evertec Inc nak IPO év 2013 van
- Virtus Health nak IPO év 2013 van
- Antero Resources Corp nak IPO év 2013 van
- Murphy USA Inc nak IPO év 2013 van
- Kodal Minerals Plc nak IPO év 2013 van
- Agios Pharmaceuticals Inc nak IPO év 2013 van